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Cationic local anesthetics (tertiary amines) recently have been demonstrated 
to influence membrane-dependent responses to surface stimuli in a  variety of 
cultured cells (1-4).  In murine BALB/3T3  cells,  for example, dibucaine, pro- 
caine, and tetracaine caused enhanced susceptibility to agglutination by concan- 
avalin A (1, 2) as well as disorganization of membrane-associated cytoskeletal 
elements (2, 3). These, and other effects of  local anesthetics, such as inhibition of 
ligand-induced capping (2, 4), could be mimicked by treatment of cells simulta- 
neously with colchicine and cytochalasin B,  agents which putatively interfere 
with the function of microtubules and microfilaments, respectively (1-3,  5-7). 
Consequently, it has been suggested that local anesthetics interact with these 
structural  and  contractile  elements of cells  so  as  to  interfere with  normal 
transmembrane control of surface receptor mobility (1-3). 
Microtubules and microfilaments are now known to be essential for several 
normal responses to surface stimulation of human polymorphonuclear leuko- 
cytes (PMN). 1 Treatment of these cells with cytochalasin B and/or colchicine 
alters their morphology (8, 9) and interferes with directed motility (10, 11) and 
particle ingestion (10, 12, 13). Colchicine, in micromolar concentrations, inhibits 
microtubule assembly in both normal and cytochalasin B-treated PMN  (14). 
Furthermore, colchicine partially inhibits release into the surrounding medium 
(exocytosis) of lysosomal enzymes from PMN exposed to ingestible particles and 
nonphagocytosable stimuli (9, 14-18). Since these effects of colchicine and cyto- 
chalasin B have been documented and quantitated, it was of interest to compare 
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the effects of local anesthetics with those of colchicine and cytochalasin B with 
respect to their capacity to influence human PMN function and morphology in 
vitro. 
Materials and Methods 
Leukocyte  Suspensions.  Leukocytes  (approximately  85%  PMN)  were  prepared  from  venous 
blood as previously described (19) and suspended in phosphate (10 mM)-buffered 140 mM NaC1, pH 
7.4,  supplemented with  0.6  mM  CaCI,  and  1.0  mM  MgC1,.,. This buffer was  used  throughout. 
Aliquots of cell suspensions containing 2-4 x  10  ~ PMN were transferred to 10 x  75 mm polypropyl- 
ene tubes (Falcon Plastics, Div. of BioQuest, Oxnard, Calif.). Some cells were preincubated with 
cytochalasin B (5.0 ~g/ml) (ICI Research Laboratories, Alderly Park, Cheshire, England) in 0.1% 
dimethyl sulfoxide  (Matheson,  Coleman,  and Bell,  East Rutherford,  N.  J.)  at 37°C  for 10 min 
before addition of appropriate compounds and stimuli. This concentration of dimethyl sulfoxide 
did not influence cytochrome c reduction, enzyme release, enzyme asays, or morphology of PMN 
(see below). 
Stimuli.  Zymosan  (ICN  Nutritional Biochemicals Div.,  International Chemical  &  Nuclear 
Corp., Cleveland, Ohio) was boiled and washed with 140 mM NaC1 and then incubated with fresh 
human serum at a concentration of 10 mg/ml for 30 min at 37°C. After centrifugation and washing 
twice, this preparation of serum-treated zymosan (STZ) was suspended in buffer at a concentration 
of 10.0 mg/ml. 
Fresh autologous serum containing 250 mM epsilon-aminocaproic acid (EACA) (Sigma Chemi- 
cal Co.,  St.  Louis,  Mo.) was incubated with zymosan  (1.0 mg/ml) at 37°C  for 15 min and then 
rendered free of particles by centrifugation (3,000 g).  Previous studies have established that the 
bulk of lysosomal enzyme releasing activity in zymosan-treated serum containing EACA (EACA- 
ZTS) can be attributed to its content of the low molecular weight complement component, CSa (18). 
EACA-ZTS was employed at a  final concentration of 10% (vol/vol). Concanavalin A  (Con A) was 
obtained from Sigma Chemical Co. 
Superoxide  Anion Production.  The generation of superoxide anion by PMN was measured as 
previously described (20).  Briefly, duplicate reaction mixtures containing 0.075 mM horse heart 
ferricytochrome c, type III (Sigma Chemical Co.) were incubated with compounds and stimuli for 
15 min at 37°C.  Incubations were terminated by sedimenting the cells at 755 g  for 10 min at 4°C. 
Supernates were diluted with buffer and the absorbance spectrum measured from 540 to 560 nm. 
With the aid of ferricyanide and dithionite, the amount of cytochrome c that was reduced and the 
total  amount  of cytochrome c  present were  calculated,  using an absorbance coefficient of 21.1 
mM -1 cm -1 at 550 nm (reduced -  oxidized) (20,  21). The specificity of cytochrome c reduction was 
checked by  assaying supernates from reaction mixtures to which had been added 0.01  mg/ml 
superoxide dismutase (Truett Laboratories, Dallas, Texas) in addition to appropriate compounds 
and stimuli. Superoxide generation is expressed as nanomoles cytochrome c reduced per 10" PMN. 
Lysosomal Enzyme Release.  The extracellular release  of PMN  granule-associated enzymes 
was measured as previously described (16-18) in duplicate reaction mixtures identical to those 
employed for the determination of superoxide generation, but in the absence of cytochrome c. After 
incubation, the reaction mixtures were centrifuged in the cold and cell-free supernates removed 
for  enzyme  assays.  Beta-glucuronidase  was  determined after  18  h  of incubation with  phenol- 
phthalein glucuronidate (Sigma Chemical Co.) as substrate (22). Lysozyme was determined by the 
rate  of  lysis  of Micrococcus  lysodeikticus  (Worthington  Biochemical  Corp.,  Freehold,  N.  J.) 
measured by decrease in absorbancy at 450 nm (23).  Crystalline hen egg-white lysozyme (Worth- 
ington Biochemical Corp.) was used as a standard. The cytoplasmic enzyme, lactate dehydrogen- 
ase (LDH) was measured as described previously (24) and used as an indicator of cell viability (16- 
18, 25).  Total enzyme activities were determined in simultaneously run duplicate reaction mix- 
tures to which had been added the detergent Triton X-100 (0.2%, vol/vol) (Rohm and Haas Co., 
Philadelphia, Pa.). 
Binding of Con A  to PMN.  For these experiments, purified preparations (98  _+  1%) of PMN 
were obtained by means of Hypaque/Ficoll gradients (26). To these (5 x  l0  s PMN) were added 0.16 
~Ci  (0.26  tzg) 3H-Con A  (New England Nuclear,  Boston, Mass.) plus 30 ~g of unlabeled lectin. 
After 15 min of incubation, the PMN were sedimented (155g for 10 min), washed three times with 
buffer, and allowed to dry at room temperature. The dried pellets were digested with 0.5 ml of 0.2 I.  M.  GOLDSTEIN,  S.  LIND,  S.  HOFFSTEIN,  AND  G.  WEISSMANN  485 
TABLE  I 
Enzyme Release from Human PMN Exposed to STZ: Effects of  Lidocaine and Tetracaine 
Additions to PMN* 
Enzyme  released$ 
(n)  ~-Glucuronidase  Lysozyme  LDH 
None  (11)  2.6  ±  0.3  1.6  ±  0.2  8.8  ±  1.8 
STZ (control)  (11)  15.4 ±  0.6  8.1  ±  0.4  9.6  ±  2.2 
STZ +  lidocaine  (14 raM)  (5)  8.9  ±  1.1  <0.001§  4.9  ±  0.3  <0.001§  23.4  ±  4.4  <0.005§ 
STZ +  lidocaine  C7 raM)  (5)  12.3  ±  1.9  <0.05  6.7  ±  0.3  <0.025  18.1  ±  2.3  <0.025 
STZ  +  tetracaine  (1.0 mM)  (6)  4.5  ±  0.4  <0.001  2.1  ±  0.2  <0.001  15.2  _+  2.4  >0.05 
STZ + tetracaine  (0.5 raM)  (6)  8.2 ± 0.5 <0.001  5.0 ± 0.3 <0.001  12.8 ±  2.2 >0.I 
STZ + tetracaine  (0.25 raM)  (6)  11.4 ± 0.7 <0.001  8.4 ± 0+3 <0.01  I0+3 ± 2.1 >0.5 
* PMN were incubated  with STZ (1.0 mg/ml)  ±  local anesthetic  for 15 rain at 37°C. 
$  B-glucuronidase,  micrograms  phenolphthalein/18  h/2  x  106 PMN;  lysozyme,  micrograms crystalline  hen  egg-whito  lysozyme 
equivalents/2  ×  10  ~ PMN; LDH, abeorbance units/2  ×  106 PMN+ Total activity released by 0.2% Triton X-100: ~-glucuronidase  = 
280  ±  24; lysozyme  =  79.5 ±  8.9;  LDH  =  895  ±  26.  Mean  ±  SEM.  (n)  =  number  of experiments. 
§ P  vs. control  (Student's t  test). 
N NaOH for 2 h at 56°C, followed by the addition of 0.2 ml of 3.0% acetic acid and 0.5 ml of  distilled 
water. Aliquots (1.0 ml) were added to 20 ml Bray's solution (New England Nuclear) and counted 
in a Beckman LS-100 liquid scintillation counter (Beckman Instruments, Inc., Spinco Div., Palo 
Alto, Calif.). Results have been expressed as counts per minute per 5 x  108 PMN. 
Other Compounds.  Lidocaine HCI  (Astra Pharmaceutical Products, Inc., Worcester, Mass.) 
and tetracaine HC1  (Schwarz/Mann Div.,  Becton,  Dickinson &  Co.,  Orangeburg,  N.  Y.)  were 
prepared daily in buffer. Xanthine and xanthine oxidase were from Sigma Chemical Co. 
Electron Microscopy and Morphology.  Replicate cell suspensions were fixed at room tempera- 
ture as described previously (8), and embedded in Spurr's low viscosity epoxy. Lead citrate-stained 
sections were viewed in a  Zeiss EM 9S Microscope (Carl Zeiss, Inc., New York).  All centrioles 
visible on six sections cut from each of three experiments were photographed at  ×  17,000 and 
printed at ×  50,000 on high contrast paper. Pericentriolar microtubules were counted from all of 
the centrioles photographed as described (18). Profiles were considered to be microtubules if they 
had straight, parallel sides, 24-28 nm apart, were at least 55 nm long, and were more electron 
dense than the ground cytoplasm. Microtubules were counted in a 2 × 2/~m square centered upon 
a centriole. 
Results 
Lysosomal  Enzyme  Release.  As  has  been  reported  previously  from  this 
laboratory  (16,  17,  20,  25,  27),  normal  human  PMN  selectively  release,  or 
secrete, lysosomal but not cytoplasmic enzymes upon exposure to phagocytosa- 
ble particles such as STZ. Such enzyme release very likely occurs by a  mecha- 
nism which has been termed "regurgitation  during feeding" (25,  27),  whereby 
fusion of lysosomal granules with incompletely closed, newly forming,  phago- 
somes  results  in  the  leakage  of granule  constituents  into  the  extracellular 
environment.  Enzyme  release  from  cells  exposed to  STZ  in  the  presence  or 
absence of local anesthetics is shown in Table I. Depending upon the anesthetic 
agent and the concentration at which it was employed, enzyme release in this 
experimental system could be significantly reduced. Appropriate control experi- 
ments excluded the possibilities that particles or other test reagents interfered 
with the enzyme assays or that there was selective adsorption of enzymes to cells 
or particles  after their  release  into  the  suspending  buffer.  In  several  experi- 
ments,  reduction  of lysosomal  enzyme  release  by the  local  anesthetics  was 
associated  with  increased  leakage  of the  cytoplasmic enzyme,  LDH  into  the 
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TABLE II 
Enzyme Release from Cytochalasin  B-Treated Human PMN: Effect of Tetracaine 
Additions to PMN* 
Enzyme released* 
(n)  ~-Glucuronidase  Lysozyme  LDH 
None  (14)  2.9 ±  0.3  1,8 ±  0.2  10.4 ±  1.9 
STZ (Control)  24,6 ±  1.7  15.5 ±  0.6  13.8 ±  2.2 
STZ +  tetracaine I1.0 raM)  17)  10,3 ±  1.3 <0,001§  6.6 ±  0.4 <0.001§  16.9 ±  2.5 >0.1§ 
STZ  +  tetracaine (0,5 mM)  17)  17.2 ±  1,5 <0,01  10.5 ±  0,4 <0.01  15.4 ±  2.1 >0.5 
STZ +  tetracaine (0.25 raM)  (7)  19.8 ±  1.7 <0.05  12.3 ±  0.5 <0,05  14.5 ±  2,2 >0,5 
EACA-ZTS (Control)  {7)  63.7 ±  2,4  24.8 ±  0,7  14.4 ±  2.1 
EACA-ZTS +  tetracaine (1.0 mM)  (7)  8.6 ±  0,7 <0.{}01  2,4 ---  0.3 <0.001  18,1  ±  1.9 >0.1 
EACA-ZTS +  tetracaine (0.5 mM)  (7)  33.7 ±  1.9 <0.001  12.3 ±  0.6 <0.001  15.0 ±  2.1 >0.5 
EACA-ZTS +  tetracaine (0.25 raM)  (7)  48.9 ±  2,0 <0,01  19.7 ±  0.7 <0.05  14.0 ±  2.3 >0.5 
* PMN  were incubated at 37°C for I0 min with cyt~chalasin  B  (5.0  ~g/ml) before the addition of  STZ (I.0  mg/ml) or EACA-ZTS 
~10~, vol/vol).  Cells were incubated with stimuli ± tetracaine for 15 rain at 37°C. 
* As described in Table I. Mean ± SEM. (n) = number of  experiments. 
§  P vs. control (Student's t  test). 
high concentrations of lidocaine; consequently, only tetracaine was employed in 
the experiments described below/ 
In preliminary experiments, we observed that lidocaine and tetracaine signif- 
icantly reduced the initial rate of ingestion by PMN of opsonized paraffin oil/oil 
red O  droplets (13) (36%  with 14 mM lidocaine,  37% with 1.0 mM tetracaine). 
Consequently,  the  local  anesthetics  could  have  reduced  lysosomal  enzyme 
release from PMN exposed to STZ simply by diminishing phagocytosis; particle 
ingestion is probably a prerequisite for maximal enzyme release in this experi- 
mental system. In order to examine this possibility, we measured the effects of 
tetracaine upon selective lysosomal enzyme release in experimental systems in 
which phagocytosis could be excluded as a  variable. 
Cytochalasin B-treated PMN respond to the particulate stimulus, STZ, and to 
the soluble stimulus, EACA-ZTS by selectively releasing lysosomal enzymes (8, 
14, 16-18, 20, 25). Surface stimulation of these cells, in the absence of phagocyto- 
sis, facilitates membrane fusion between lysosomal membranes and the plasma 
membrane leading to the discharge of granule contents into the external envi- 
ronment  as  if into  a  phagocytic  vacuole  (exocytosis).  As  was  the  case  with 
normal  cells exposed to STZ,  tetracaine  significantly reduced enzyme release 
from cytochalasin B-treated PMN exposed either to STZ or to EACA-ZTS (Table 
II). 
Another  stimulus  for  enzyme  secretion  by  PMN  which  does  not  require 
phagocytosis (or cytochalasin B) is Con A  (19,  28). In contrast to other stimuli, 
however,  Con  A  provokes  the  discharge  from  these  cells  only  of lysozyme; 
azurophil  granule constituents (e.g., beta-glucuronidase) are not released.  Con 
A-mediated lysozyme release from normal human PMN was also reduced signif- 
icantly by tetraeaine  (data not shown). 
Thus, it appeared that tetracaine, at concentrations which were not cytotoxic, 
was  capable  of interfering  with  the  complex  process  of exocytosis in  PMN 
regardless  of the  manner  in  which  the  cells  were  stimulated.  Inhibition  of 
particle ingestion could be excluded as accounting for this effect. Whereas these 
Dibucaine, procaine, and butacaine similarly caused leakage of LDH from PMN at concentra- 
tions which reduced lysosomal enzyme release. I.  M.  GOLDSTEIN, 
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FIG.  1.  Influence of tetracaine upon the generation of superoxide anion by normal (stip- 
pled bars) and by cytochalasin B-treated (hatched bars) PMN exposed to STZ.  PMN were 
preincubated with cytochalasin B (5.0 ~g/ml) for 10 min before exposure to STZ (1.0 mg/ml) 
for 15 min at 37°C.  Superoxide anion generation was measured as superoxide dismutase- 
inhibitable cytochrome c reduction. Mean -+ SEM, number of experiments (n), 7. Superox- 
ide anion generation was reduced significantly by tetracaine (P <  0.001 with 1.0 mM and 0.5 
mM, P  <  0.025 with 0.25 mM). 
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findings were  quite  consistent  with  either  direct  or  indirect  effects  of this 
anesthetic agent upon cytoskeletal elements and/or membrane fusion as the 
mechanism whereby it  inhibited enzyme release,  they did  not  rule  out  the 
possiblity that this agent acted by influencing the manner in which the various 
stimuli interacted with the cell surface to generate the "signals" that provoke 
exocytosis. Therefore, we examined the effect of tetracaine upon another conse- 
quence of PMN cell surface stimulation. 
Superoxide Anion Generation.  Human PMN respond to appropriate particu- 
late and soluble stimuli with a  marked increase in oxidative metabolism (29). 
PMN generate superoxide anion (measured as superoxide dismutase-inhibitable 
cytochrome c reduction) in a time- and concentration-related fashion independ- 
ently of phagocytosis (19, 20). The responses of normal and of cytochalasin B- 
treated PMN to STZ are shown in Fig. 1. As was the case with lysosomal enzyme 
release, superoxide generation was reduced significantly  by the local anesthetic, 
tetracaine. This effect of tetracaine was not due simply to its ability to interfere 
with the assay system since it was found not to influence the measurement of 
superoxide generated in an experimental system employing xanthine and xan- 
thine oxidase (30). Tetracaine also significantly reduced superoxide generation 
by normal PMN exposed to Con A  (data not shown). The effect of tetracaine 
upon the generation of superoxide by PMN, as well as its effect upon release of 
lysosomal enzymes, was completely reversible. Cells exposed to tetracaine for 15 
min at 37°C and then washed only once with buffer, responded comparably to 
normal cells when subsequently challenged with either STZ or Con A. 
Binding of Con A  to PMN.  The possibility that tetracaine may have influ- 
enced contact between the various stimuli and the PMN surface membrane was 
examined by measuring the effect of tetracaine upon binding of 3H-Con  A  to 
these cells. Tetracaine (1.0 mM) had virtually no effect upon lectin-binding at 
4°C. At 37°C, however, the uptake of3H-Con A by PMN was reduced (4,160 _+ 340 488  LOCAL  ANESTHETICS  AND  LEUKOCYTE  FUNCTION 
cpm  vs.  5,530  __-  480  cpm,  P  <  0.05)  in  the  presence  of the  anesthetic.  This 
reduction,  which  may have reflected either diminished  endocytosis of labeled 
lectin or fewer binding sites as a consequence of diminished exocytosis, was very 
likely insufficient by itself to account for the markedly diminished response to 
Con  A  by  tetracaine-treated  cells  as judged  from  previously  reported  dose- 
response and binding studies  (19, 28). 
Electron Microscopy.  PMN exposed to tetracaine were conspicuously differ- 
ent from their untreated counterparts when examined with the electron micro- 
scope. Compared to normal cells which have membrane ruffles and pseudopedia 
(Fig.  2 a),  tetracaine-treated PMN  were smooth and rounded with  centrioles 
located in the geometric center of the spherical cell (Fig. 2 b). This change was 
similar to that reported in anesthetic-treated mouse macrophages (31), but was 
quite different from the changes in shape seen in PMN treated with cytochalasin 
B  and/or colchicine. Cytochalasin B-treated PMN are rounded but not smooth 
surfaced,  and  in  thin  sections  the  retracted  plasma  membrane  appears  as 
invaginations toward centrally located centrioles (8,  9,  14).  Colchicine-treated 
cells are irregular in shape with centrioles and Golgi apparatus displaced from 
their usual position and have a  markedly reduced number of microtubules  (9, 
14,  16).  Microtubules  in  tetracaine-treated  PMN  were  not  distinguishable  in 
appearance, location, or number from those in corresponding control, unstimu- 
lated  cells.  Microtubule  assembly  in  response  to  stimulation,  however,  was 
affected by pretreatment with tetracaine. Although the number of microtubules 
visible within a 2  x  2 ~m square centered over the centriolar regions of treated 
and untreated cells was similar in the absence of stimulation (25.6 +__ 2.5 vs. 28.2 
+- 1.6, P  >  0.5), the number visible after stimulation with Con A, for example, 
was  increased only in  untreated  cells  (39.9  -+  2.3).  Tetracaine  (1.0  mM)  pre- 
vented this  increase  (25.6  +_  2.6, P  <  0.001).  A  single  wash  with buffer was 
sufficient to restore the ability of tetracaine-treated PMN to respond normally to 
Con A. 
Other morphologic responses to stimulation with Con A were very different in 
tetracaine-treated as compared to untreated PMN.  In untreated cells,  areas of 
the  plasma  membrane  were  invaginated  to  form  narrow  channels  which  in 
cross-section  appeared  as  vacuoles  (insert  Fig.  2  a).  In  contrast,  the  plasma 
membrane of tetracaine-treated PMN  exposed to Con A  remained  smooth  and 
unruffled.  Numerous  microfilaments  were  visible  in  the  subplasmalemmal 
cytoplasm (insert Fig. 2 b). 
Discussion 
The cationic local anesthetic agent, tetracaine reversibly inhibited two mem- 
Fro.  2.  (a) An untreated, normal human PMN sectioned through a centriole. The cell is 
irregular in profile with agranular pseudopodic extensions,  x 11,000. Insert:  A portion of 
the peripheral cytoplasm of a Con A-stimulated, untreated PMN. The membrane is thrown 
up into folds and regions bearing Con A-binding sites are being internalized.  Microfila- 
ments (arrows) are visible in the cytoplasm, x 24,000. (b) A similar section ofa tetracaine- 
treated PMN. The cell profile is smooth and the granules appear larger and more densely 
stained  than controls,  x  11,000. Insert: The peripheral cytoplasm of a Con A-stimulated, 
tetracaine-treated PMN showing a circumferential  arrangement of microfilaments but no 
change in the shape of the plasma membrane,  x 24,000. 489 490  LOCAL  ANESTHETICS  AND  LEUKOCYTE  FUNCTION 
brane-dependent responses of human PMN to surface stimulation; exocytosis of 
granule-associated  enzymes  and  generation  of superoxide  anion.  These  two 
responses  occur  independently  in  stimulated  cells  (19,  20)  and  can  also  be 
influenced  by pharmacologic  agents  which  directly  or  indirectly  affect  micro- 
tubules, microfilaments, and cell membranes. For example, inhibition of micro- 
tubule assembly by colchicine modestly reduces release of lysosomal enzymes 
but  has  little,  if any,  influence  upon  the  generation  by stimulated  PMN  of 
superoxide  anion  (14,  32).  Cytochalasin  B, by inhibiting  interaction  of actin- 
binding protein and actin, interferes with subplasmalemmal microfilaments (7). 
Consequently, it enhances exocytosis and has variable effects upon PMN metab- 
olism  (depending  upon  the  stimulus)  (20,  32).  Membrane-stabilizing  agents, 
such  as certain  adrenal  corticosteroids,  reduce both enzyme release as well as 
superoxide generation (33). Thus, the effects of tetracaine upon PMN exposed to 
surface stimuli resemble most the effects of corticosteroids. 
Whereas tetracaine  may have influenced the function of cytoskeletal and/or 
contractile elements of PMN to produce the altered responses to surface stimuli 
which we observed, our results are also consistent with an effect of this com- 
pound upon the membranes of the cell. Indeed, ultrastructural alterations were 
observed primarily in the surface membranes of treated PMN. Gross changes in 
the morphology of microtubules and microfilaments, as observed in 3T3 cells (3), 
were not seen in tetracaine-treated human PMN, although microtubule assem- 
bly in response to stimulation was inhibited. 3 This supports the possibility that 
the function of these structures  was affected so as to alter normal  transmem- 
brahe control of surface receptor mobility. In fact,  such an effect is consistent 
with the alterations of cell shape observed after tetracaine treatment as well as 
with some of the results of our biochemical studies demonstrating  diminished 
exocytosis.  Nevertheless,  some of the  most dramatic  changes  attributable  to 
tetracaine  treatment  were metabolic and were unlikely to be due to effects of 
this compound upon either microtubules or microfilaments.  Our data suggest, 
therefore, that tetracaine may act upon the membranes of PMN so as to modify 
stimulus-membrane interactions and retard membrane fusion much in the same 
fashion as corticosteroids (33). 
Cationic  local anesthetics affect biological membranes  in a  variety of ways 
(reviewed in reference 35). In excitable tissues, for example, they block sodium 
channels  and,  consequently,  inhibit  membrane  depolarization  by reducing so- 
dium  and  potassium  conductances  (36).  More  general  effects of these  agents 
upon  membranes  have  been  attributed  to both hydrophobic  and  electrostatic 
interactions  with  acidic  phospholipids  (37,  38)  as  well  as  to  their  ability  to 
displace calcium ions from membrane  sites  (35,  39,  40).  These effects produce 
expansion  of membranes  and  promote  membrane  stability  (35).  It  should be 
noted,  however, that  at high  concentrations,  cationic anesthetics enhance the 
fluidity  of membrane  phospholipds  and  may  even  cause  lysis  of perturbed 
bilayers (35, 38). Local anesthetics also have been reported to prevent mobiliza- 
tion of internal  stores of calcium in various types of cells (41).  These effects of 
local anesthetics can be manifested by a  variety of altered cellular functions. 
They reduce osmotic fragility of erythrocytes (35, 42), inhibit cell fusion (43, 44), 
3 Lidocaine has been reported to inhibit rabbit brain microtubule assembly in vitro  (34). I.  M.  GOLDSTEIN,  S.  LIND,  S.  HOFFSTEIN,  AND  G.  WEISSMANN  491 
decrease cell-to-cell  as well as cell-to-substrate  adhesion  (45,  46),  and  inhibit 
exocytosis in such secretory cells as platelets  (47),  mast cells  (48),  chromaffin 
cells of the adrenal medulla (49),  and beta-cells of the pancreas  (50).  In phago- 
cytic  cells,  such  as  macrophages  and  PMN,  they  alter  cell  shape  (31)  and 
diminish spreading (31, 45), locomotion (51), and particle ingestion (with associ- 
ated metabolic changes)  (52). 
The effects of tetracaine  upon PMN responses to surface stimulation  which 
are described in this report can be explained by several of the aforementioned 
effects of this  compound upon biomembranes,  particularly  those that  interfere 
with  stimulus-response  coupling  and  membrane  fusion.  Whereas  it  is  also 
possible that tetracaine  acted upon microtubules and microfilaments,  or their 
membrane  attachments  in human  PMN, the data suggest that the actions of 
tetracaine in this cell type are not mimicked, as they appear to be in others (1- 
3), by the combined actions of cytochalasin B and colchicine. The reasons for this 
are unclear. Whatever the explanation may be, our results provide an exception 
to a recently hypothesized "general" mechanism of action of local anesthetics. 
Summary 
Cationic local anesthetics have been reported to influence cellular responses 
to surface stimuli by interfering with the function of microtubules and microfila- 
ments. Since unimpaired microtubule and microfilament functions are required 
by human polymorphonuclear leukocytes in order to respond normally to sur- 
face stimulation,  we have studied effects of the local anesthetic,  tetracaine  on 
the function and morphology of these cells in vitro.  Tetracaine  (0.25-1.0 mM) 
significantly  reduced  extracellular  release  of the  lysosomal  enzymes,  beta- 
glucuronidase  and  lysozyme  from  polymorphonuclear  leukocytes  exposed  to 
serum-treated  zymosan  (a  particulate  stimulus),  zymosan-treated  serum  (a 
soluble stimulus),  and to the surface-active lectin, concanavalin A. Tetracaine 
also significantly reduced superoxide anion production  (superoxide dismutase- 
inhibitable cytochrome c reduction) by these cells. Tetracaine was not cytotoxic 
and its effects could be reversed completely by washing cells once with buffer. 
Electron  microscope examination  of tetracaine-treated  cells revealed marked 
alterations  of surface membranes.  Microtubules and microfilaments  appeared 
normal in "resting" polymorphonuclear leukocytes, but the increase in microtu- 
bules  normally  observed  in  stimulated  cells  was  not  seen  after  tetracaine 
treatment.  These results suggest that tetracaine interferes with those interac- 
tions  between  immune  reactants  and  the  polymorphonuclear  leukocyte  cell 
surface which provoke exocytosis and increased oxidative metabolism. 
The authors thank Howard B. Kaplan and Doris Gennaro for their expert technical assistance. 
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